| Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.090 | AlteredExpression | disease | BEFREE | COX-2 gene expression and methylation profile in Sapajus apella as an experimental model for gastric adenocarcinoma. | 29767663 | 2019 | ||||
|
0.090 | AlteredExpression | disease | BEFREE | The immunohistochemistry was used to study the expression of COX-2 on 93 patients with gastric adenocarcinoma. | 27314294 | 2016 | ||||
|
0.090 | Biomarker | disease | BEFREE | As a consequence, the expression of COX-2 and PCNA was found in cancer tissues with a higher strong reactivity rate, compared with the ANCTs (80.0 vs. 53.3%, P=0.011; 68.9 vs. 48.9%, P=0.047), and COX-2 was positively associated with lymph node metastasis of GAC patients (P=0.011). | 24992958 | 2014 | ||||
|
0.090 | AlteredExpression | disease | BEFREE | We conclude that Hp promotes apoptosis in adenocarcinoma gastric epithelial cells in vitro and this is associated with activation of COX-2 and inhibition of HSP70. | 22610150 | 2012 | ||||
|
0.090 | GeneticVariation | disease | BEFREE | -765G > C COX-2 polymorphism with or without H pylori could be a marker for genetic susceptibility to gastric adenocarcinoma. | 18330937 | 2008 | ||||
|
0.090 | GeneticVariation | disease | BEFREE | -765G > C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia. | 17006983 | 2006 | ||||
|
0.090 | Biomarker | disease | BEFREE | COX-2 may contribute to progression of tumor in human gastric adenocarcinoma. | 12532441 | 2003 | ||||
|
0.090 | AlteredExpression | disease | BEFREE | Cox-2 is expressed by the neoplastic cells in the intestinal-type gastric adenocarcinoma and by precarcinogenic (dysplastic) lesions leading to this disease. | 11448905 | 2001 | ||||
|
0.090 | Biomarker | disease | BEFREE | These results provide clinical evidence that COX-2 may contribute to tumor progression in human gastric adenocarcinoma. | 11223821 | 2001 |